BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2902608)

  • 1. [Comparative studies on the effectiveness of inhalant beta 2 mimetics therapy in patients with obstructive respiratory disorders].
    Würtemberger G; Weil R; Schulte-Mönting J; Matthys H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():304-6. PubMed ID: 2902608
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of onset of bronchodilating effect by interruption of the air flow method.
    Lulling J; Delwiche JP; Prignot J
    Eur J Respir Dis; 1980 Apr; 61(2):108-12. PubMed ID: 7002572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral therapy with beta-2-sympathomimetic drugs: comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients with reversible airway obstruction].
    Morr H; Nink M; Ferlinz R
    Pneumologie; 1990 Apr; 44(4):739-43. PubMed ID: 2192369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of tulobuterol and salbutamol in chronic obstructive pulmonary disease.
    Germouty J
    Clin Ther; 1986; 8(5):546-53. PubMed ID: 2876775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cardiorespiratory effects of rimiterol and terbutaline aerosols.
    Harris L
    Bull Physiopathol Respir (Nancy); 1974; 10(6):801-10. PubMed ID: 4156915
    [No Abstract]   [Full Text] [Related]  

  • 6. Tulobuterol in the management of obstructive airways disease in adults.
    Patel KR
    Clin Ther; 1985; 7(4):452-67. PubMed ID: 2861899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of salmeterol in the treatment of smokers with chronic obstructive lung disease].
    Ulrik CS
    Ugeskr Laeger; 1996 Jun; 158(25):3604-7. PubMed ID: 8693619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Broncholytic activity of dose-adjusted aerosols in active respiratory tuberculosis].
    Vizel' AA; Iaushev MF; Mustafin RR; Goncharova LV
    Probl Tuberk; 1995; (2):7-9. PubMed ID: 7777469
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of various beta 2-adrenergic bronchodilator agents in CARD patients].
    Kreukniet J
    Ned Tijdschr Geneeskd; 1977 Jun; 121(23):936-40. PubMed ID: 876421
    [No Abstract]   [Full Text] [Related]  

  • 10. Bronchodilator effects of terbutaline and theophylline alone and in combination in patients with chronic obstructive lung disease.
    Baadsgaard O; Oberg B; Thomsen L; Klitgaard N; Simonsen E
    Allergol Immunopathol (Madr); 1985; 13(6):471-4. PubMed ID: 2870630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eformoterol versus salbutamol in patients with ROAD.
    Maesen FP
    Br J Clin Pract Suppl; 1995 Sep; 81():8-10. PubMed ID: 8546895
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial diseases--for].
    Muir JF; Cuvelier A
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S75-6. PubMed ID: 10088257
    [No Abstract]   [Full Text] [Related]  

  • 13. Eformoterol versus salbutamol in elderly patients with ROAD.
    Hendrick DJ
    Br J Clin Pract Suppl; 1995 Sep; 81():4-5. PubMed ID: 8546893
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of the effectiveness of beta-adrenergic stimulatin drugs].
    Palmer KN
    Minerva Med; 1976 Apr; 67(17):1095-102. PubMed ID: 4756
    [No Abstract]   [Full Text] [Related]  

  • 15. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of the effectiveness and tolerance of a new beta-2 stimulant (broxaterol) vs. salbutamol in patients with chronic obstructive bronchopneumopathy].
    Giosuè S; Guerrini P; Cafaggi R; D'Onofrio V; Perrone N; Scano M
    Clin Ter; 1987 Apr; 121(1):35-9. PubMed ID: 2885123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Basic medication of chronic obstructive lung disease with berodual].
    Melent'eva EM
    Klin Med (Mosk); 1999; 77(7):47-8. PubMed ID: 10483166
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect duration and treatment effectiveness of salmeterol, fenoterol and salbutamol in severe forms of respiratory tract obstruction].
    Vollmer M; Schmidt EW; Ulmer WT
    Pneumologie; 1995 Oct; 49(10):528-34. PubMed ID: 8584522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-month comparative study of tulobuterol aerosol versus fenoterol aerosol in patients with chronic obstructive lung disease.
    Werdermann K
    Lung; 1990; 168 Suppl():202-9. PubMed ID: 1974678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled aerosol comparison of two inhalations of ibuterol with two of fenoterol.
    Minette A; Marco M
    Acta Tuberc Pneumol Belg; 1978; 69(2):99-106. PubMed ID: 747144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.